Abstract
Diabetes mellitus impacts virtually every organ system of the body due to the influence that altered glucose metabolism imparts on cellular physiology and because of the effect chronic hyperglycemia can have on protein glycosylation states. As a physiological process involving multiple cell types, biomolecules, and a requirement for cell activation and activity, wound healing processes from formation of a transitional extracellular matrix after tissue destruction to altered neutrophil activation to a reduction in effective mesenchymal cell function have all been shown to be impacted by diabetes. In this chapter, we will review numerous studies that have documented changes in different components of classic dermal wound healing due to chronic hyperglycemia producing an overall diminished capacity to heal tissues and to even lead to the formation of ulcerations. Lastly, we will briefly discuss recent findings from our own studies that suggest that the diabetic state may alter the ability of fibroblasts to respond to activation stimuli with the appropriate expression of pro-inflammatory mediators. This aberrant expression could ultimately lead to an over-recruitment of neutrophils and/or monocyte/macrophages leading to a failure to heal a wound.
Abbreviations
- bFGF:
-
Basic fibroblast growth factor
- CCR:
-
CC chemokine receptor
- CXCR:
-
CXC chemokine receptor
- ECM:
-
Extracellular matrix
- HIF-1α:
-
Hypoxia-inducible factor-1α
- IL:
-
Interleukin
- LPS:
-
Lipopolysaccharide
- MCP-1:
-
Monocyte chemoattractant protein-1
- MMP:
-
Matrix metalloproteinase
- NO:
-
Nitric oxide
- PDGF:
-
Platelet-derived growth factor
- TGFβ:
-
Transforming growth factor-β
- TIMP:
-
Tissue inhibitor of matrix metalloproteinase
- TLR:
-
Toll-like receptor
- TNFα:
-
Tumor necrosis factor-α
References
Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958–65.
Undas A, Ariës RAS. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Int J Biochem Cell Biol. 2012;44:1800–12.
Jaleel A, Halvatsiotis P, Williamson B, et al. Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment. Diabetes Care. 2005;28:645–52.
Dunn EJ, Philippou H, Ariës RA, et al. Molecular mechanisms involved in the resistance of fibrin clot lysis by plasmin in subjects with type 2 diabetes mellitus. Diabetologia. 2006;49:1071–80.
Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8:504–12.
Tedder TF, Steeber DA, Chen A, et al. The selectins: vascular adhesion molecules. FASEB J. 1995;9:866–73.
Soehnlein O, Zernecke A, Weber C. Neutrophils launch monocyte extravasation by release of granule proteins. Thromb Haemost. 2009;102:198–205.
Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259–65.
Nguyen KT, Seth AK, Hong SJ, et al. Deficient cytokine expression and neutrophil oxidative burst contribute to impaired cutaneous wound healing in diabetic, biofilm-containing chronic wounds. Wound Repair Regen. 2013;21:833–41.
Kaplanski G, Marin V, Montero-Julian F, et al. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol. 2003;24:25–9.
Ross R, Odland G. Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol. 1968;39:152–68.
Luscinskas FW, Kansas GS, Ding H, et al. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J Cell Biol. 1994;125:1417–27.
Deonarine K, Panelli MC, Stashower ME, et al. Gene expression profiling of cutaneous wound healing. J Transl Med. 2007;5:11. doi:10.1186/1479-5876-5-11.
Ferrante CJ, Leibovich SJ. Regulation of macrophage polarization and wound healing. Adv Wound Care. 2012;1:10–6.
Nagorsen D, Deola S, Smith K, et al. Polarized monocyte response to cytokine stimulation. Genome Biol. 2005;6:R15.
Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:1–22.
Katz S, Klein B, Elian I, et al. Phagocytotic activity of monocytes from diabetic patients. Diabetes Care. 1983;6:479–82.
Maruyama K, Asai J, Ii M, et al. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol. 2007;170:1178–91.
Zykova SN, Jenssen TG, Berdal M, et al. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes. 2000;49:1451–8.
Wetzler C, Kampfer H, Stallmeyer B, et al. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol. 2000;115:245–53.
Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1:71–81.
Mori L, Bellini A, Stacey MA, et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res. 2005;304:81–90.
Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001;166:7556–62.
Ekert JE, Murray LA, Das AM, et al. Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes. Fibrogenesis Tissue Repair. 2011;4:23.
Krawczyk WS. A pattern of epidermal cell migration during wound healing. J Cell Biol. 1971;49:247–63.
Braiman-Wiksman L, Solomonik I, Spira R, et al. Novel insights into wound healing sequence of events. Toxicol Pathol. 2007;35:767–79.
Coulombe PA. Wound epithelialization: accelerationg the pace of discovery. J Invest Dermatol. 2003;121:219–30.
Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738–46.
Lan CCE, Liu IH, Fang AH, et al. Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes. Br J Dermatol. 2008;159:1103–15.
Huang SM, Wu CS, Chao D, et al. High-glucose-cultivated peripheral blood mononuclear cells impaired keratinocyte function via reduced IL-22 expression: implications on impaired diabetic wound healing. Exp Dermatol. 2015;24:639–41.
Welch MP, Odland GF, Clark RAF. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol. 1990;110:133–45.
Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol. 2007;257:143–79.
Ramasastry SS. Acute wounds. Clin Plast Surg. 2005;32:195–208.
Fowlkes V, Clark J, Fix C, et al. Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblasts. Life Sci. 2013;92:669–76.
Tonnesen MG, Feng X, Clark RAF. Angiogenesis in wound healing. J Invest Dermatol Symp Proc. 2000;5:40–6.
McClain SA, Simon M, Jones E, et al. Mesenchymal cell activation is the rate-limiting step of granulation tissue induction. Am J Pathol. 1996;149:1257–70.
Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med. 2001;125:67–71.
Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO. 1999;18:3964–72.
Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med. 2001;125:67–71.
Goddard LM, Luisa Iruela-Arispe M. Cellular and molecular regulation of vascular permeability. Thromb Haemost. 2013;109:407–15.
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–20.
Thangarajah H, Yao D, Chang EI, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A. 2009;106:13505–10.
Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449–57.
Walzog B, Jeblonski F, Zakrzewicz A, et al. Promote apoptosis of human. FASEB J. 1997;11:1177–86.
Petreaca ML, Yao M, Ware C, et al. Vascular endothelial growth factor promotes macrophage apoptosis through stimulation of tumor necrosis factor superfamily member 14 (TNFSF14/LIGHT). Wound Repair Regen. 2008;16:602–14.
Grinnell F, Zhu M, Carlson MA, et al. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res. 1999;248:608–19.
Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92–101.
Mitchell S, Thomas G, Harvey K, et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol. 2002;13:2497–507.
Godson C, Mitchell S, Harvey K, et al. Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol. 2000;164:1663–7.
Herrera BS, Hasturk H, Kantarci A, et al. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. Infect Immun. 2015;83:792–801.
Dangwal S, Stratmann B, Bang C, et al. Impairment of wound healing in patients with type 2 diabetes mellitus influences circulating microRNA patterns via inflammatory cytokines. Arterioscler Thromb Vasc Biol. 2015;35:1480–8.
Zampetaki A, Kiechl S, Drozdov I, et al. Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and other MicroRNAs in type 2 diabetes. Circ Res. 2010;107:810–7.
Gallagher KA, Joshi A, Carson WF, et al. Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes. Diabetes. 2015;64(4):1420–30.
Wang J, Hori K, Ding J, et al. Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring. J Cell Physiol. 2011;226:1265–73.
Cho J-S, Kang J-H, Um J-Y, et al. Lipopolysaccharide induces pro-inflammatory cytokines and MMP production via TLR4 in nasal polyp-derived fibroblast and organ culture. PLoS One. 2014;9(11):e90683. doi:10.1371/journal.pone.0090683.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Grant, S.E., Lindblad, W.J. (2017). Impact of the Diabetic State on Wound Healing Dynamics and Expression of Soluble Cellular Mediators. In: Mukhopadhyay, A. (eds) Regenerative Medicine: Laboratory to Clinic. Springer, Singapore. https://doi.org/10.1007/978-981-10-3701-6_1
Download citation
DOI: https://doi.org/10.1007/978-981-10-3701-6_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-3700-9
Online ISBN: 978-981-10-3701-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)